Skip to content
ContentBlick

Providing Pluripotent Cells in Utero to Infants with Neural Tube Defect Enhances Life Outcomes, Research Shows

A pioneering research effort has found that providing pluripotent cells to developing infants diagnosed with spina bifida while undergoing fetal surgery could constitute a "important advancement" in treating birth defects.

Study Parameters and Security

The American study involved six fetuses with the 'open' form of spina bifida. Surgeons applied placenta-derived mesenchymal stem cells directly onto the developing neural column while the defect was being closed.

Significantly, the stem cell application was found to be safe. The study team reported that the cells did not cause neoplasms, disrupt the healing process, or impede the resolution of associated brain abnormalities.

Positive Developments

Post-birth MRI scans indicated a successful correction of brainstem displacement in all six infants. This neurological improvement is closely linked to improved motor skills and quality of life.

"In the event it allows additional babies able to walk who wouldn't have, then it would become their standard of care," said the lead researcher. "The results are profoundly encouraging and open the door to a variety of prospective novel therapies."

Broader Impact and Encouragement

Experts not involved in the trial indicated that additional validation of these apparent benefits could herald a "fresh chapter" in fetal surgery. The potential to improve neural deficits present before birth is viewed as a paradigm-shifting aim.

Notably important would be better management of urogenital and gastrointestinal outcomes, which are common challenges for those diagnosed with this defect.

Future Directions

While this initial trial involved a limited number of patients, its confirmed tolerability and hopeful trends offer a robust platform for broader investigative efforts. The addition of cellular treatment with current in-utero repair procedures presents significant potential for improving the prognosis for future generations with myelomeningocele.

Written by

Sandra Higgins

A digital strategist with over a decade of experience in content marketing and SEO, passionate about helping brands grow their online presence.

ContentBlick

Type to search articles.